Drug Database
Back to search

Netherlands· NL-761822a3e974

Locacorten-Vioform, oordruppels

A flumetason und antiinfektiva product containing clioquinol + flumetason pivalaat, registered in Netherlands by Amdipharm Limited. The same ATC class is registered in 4 of our 19 countries.

ATC S02CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLocacorten-Vioform, oordruppelsATCS02CA02REGISTER NO.NL-761822a3e974PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clioquinol + flumetason pivalaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Flumetason und antiinfektiva is registered in 4 of 19 countries.

Countries holding a registration under ATC S02CA02 (flumetason und antiinfektiva), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 1 of them publish a price we can compare per daily dose
Search flumetason und antiinfektiva products by name

Flumetason und antiinfektiva · ATC S02CA02

4 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CLIOQUINOL + FLUMETASON PIVALAAT
Manufacturer
Amdipharm Limited
Country
Netherlands (NL)
ATC code
S02CA02
ATC class
Flumetason und Antiinfektiva
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    05628

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under S02CA02

Flumetason und antiinfektiva, as other registers publish it.

All flumetason und antiinfektiva products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6d000b79-47cb-41d5-8ab9-ff0bac475dbc
GET /v1/drugs/6d000b79-47cb-41d5-8ab9-ff0bac475dbc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oordruppels, oplossing",
  "route": "Auriculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05628_smpc.pdf",
  "strength": null,
  "atc_label": "Flumetasone And Antiinfectives",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05628",
  "excipients": [
    "MACROGOL 300"
  ],
  "substances": [
    "CLIOQUINOL",
    "FLUMETASON PIVALAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05628.pdf",
  "authorised_at": "1968/12/18",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05628",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about flumetason und antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console